Related Experiment Video
Updated: Jun 5, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Pregnancy and commonly used drugs in hematology practice
Gideon Koren1, Michael Lishner
1Motherisk Program, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada. gkoren@sickkids.ca
Abstract:
When a woman suffering from a hematological condition is contemplating pregnancy, she may need to continue the use of medications that do not have sufficient evidence of fetal safety. We discuss the evidence existing for some therapies of major hematological conditions in the context of major principles in clinical teratology. It is critical to always balance the potential fetal risks of the drug in question against the maternal and fetal risks of the untreated hematological condition.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Factors Affecting Drug Response: Overview
Therapeutic Drug Monitoring: Affecting Factors
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
